108773 ⎘
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; Animal cells or tissues; Human cells or tissues; Vertebrate cells; Cells from the blood or the immune system Granulocytes, e.g. basopils, eosinophils, neutrophils, mast cells
ENHANCEMENT OF PHAGOCYTOSIS
#2COMPOSITIONS AND METHODS FOR MICROGLIA REPLACEMENT THERAPY
#3Cancer Cytotoxic Exosome Formulations and Methods for Use in Treating Cancer
#4CAR-EXPRESSING PLURIPOTENT STEM CELL-DERIVED NEUTROPHILS LOADED WITH DRUG NANOPARTICLES AND USES THEREOF
#5METHOD FOR ENHANCING DURABILITY OF IMMUNE CELL
#6CANCER-KILLING CELLS
#7ISOLATION OF ANTI-INFLAMMATORY NEUTROPHIL OR MONOCYTE SUBSET AND USE IN TREATING CARDIOVASCULAR DISEASES
#8METHODS OF TREATING BRAIN INJURY
#9REPROGRAMMING OF IMMUNE-ENHANCING NEUTROPHILS BY SUBCLINICAL LOW-DOSE ENDOTOXIN FOR THE TREATMENT OF CANCER
#10CONSTRUCTION AND APPLICATION OF ENHANCED NEUTROPHIL DRUG
#11POLYPEPTIDES, CELLS, AND METHODS INVOLVING ENGINEERED CD16
#12INFUSION OF FRESH IMMUNE EFFECTOR CELLS ARMED WITH MULTISPECIFIC ANTIBODY
#13CHIMERIC FC-ALPHA RECEPTORS AND USES THEREOF
#14HEPARIN FROM MODIFIED MST CELLS AND METHODS OF MAKING AND USING
#15METHODS FOR THE LONG-TERM EXPANSION OF GRANULOCYTE-MACROPHAGE PROGENITORS AND APPLICATIONS THEREOF
#16COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS
#17COMPOSITIONS AND CELL CULTURE MEDIA FOR INCREASING NEUTROPHIL LIFESPAN
#18CELLS FOR TREATING INFECTIONS
#19HUMAN CHIMERIC ANTIGEN RECEPTOR NEUTROPHILS, COMPOSITIONS, KITS AND METHODS OF USE
#20MULTILAYERED BLOOD PRODUCT
#21CHIMERIC ANTIGEN RECEPTOR-MODIFIED GRANULOCYTE-MACROPHAGE PROGENITORS FOR CANCER IMMUNOTHERAPY
#22CANCER-KILLING CELLS
#23Cancer Cytotoxic Exosome Formulations and Methods for Use in Treating Cancer
#24METHOD FOR INDUCING AND DETECTING SOLUBLE LOX-1 (sLOX-1) IN CULTURED BLOOD CLOTS
#25COMBINATIONAL IMMUNOTHERAPIES USING CAR-M, CAR-NK, CAR-EOS, AND CAR-N CELLS
#26ASSAY
#27METHODS FOR TREATING INHERITED METABOLIC DISORDERS
#28HUMAN CHIMERIC ANTIGEN RECEPTOR NEUTROPHILS, COMPOSITIONS, KITS AND METHODS OF USE
#29CANCER-KILLING CELLS
#30SIRPalpha Inhibited Macrophages and Neutrophils and Uses Thereof
#31Protein Tyrosine Phosphatase 1B Inhibited Neutrophils, Neutrophil-Dendritic Cell Hybrids and Uses Thereof
#32SUPERPARAMAGNETISM-MODIFIED AND NEUTROPHIL EXOSOME BIOMIMETIC VESICLE-BASED BIOLOGICAL PREPARATION FOR DRUG DELIVERY, AND PREPARATION METHOD THEREOF
#33CELLS FOR TREATING CANCER
#34COMPOSITIONS AND METHODS FOR MICROGLIA REPLACEMENT THERAPY
#35METHODS OF MAKING OLIGOPOTENT AND UNIPOTENT PRECURSORS
#36CELLULAR TARGETED PHARMACEUTICALLY ACTIVE SUBSTANCE OR LABEL DELIVERY SYSTEM
#37Therapeutic Human Mast Cells, Compositions, and Methods of Treating a Tumor Comprising Administering Autologous Human Mast Cells from Adipose Tissue
#38THERAPEUTIC GENE EDITING FOR ELANE-ASSOCIATED DISEASE
#39HIGH EFFICIENCY MICROFLUIDIC PURIFICATION OF STEM CELLS TO IMPROVE TRANSPLANTS
#40CD11B + PIEZO-1 + MACROPHAGES AND USES THEREOF
#41Polypeptides, cells, and methods involving engineered CD16
#42Cellular Targeted Label Delivery System
#43METHODS FOR MONITORING POLYMORPHONUCLEAR MYELOID DERIVED SUPPRESSOR CELLS
#44Methods for the long-term expansion of granulocyte-macrophage progenitors and applications thereof
#45Compositions and methods of enhancing anti-tumor response using hybrid neutrophils
#46Cancer-killing cells
#47METHODS OF MODULATING M2 MACROPHAGE POLARIZATION AND USE OF SAME IN THERAPY
#48STEM-CELL DERIVED MYELOID CELLS, GENERATION AND USE THEREOF
#49Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells
#50NEUTROPHIL SUBTYPES
#51METHODS AND COMPOSITION FOR MODULATING IMMUNE RESPONSE AND IMMUNE HOMEOSTASIS
#52Compositions and methods for treating neurological disorders
#53Multilayered blood product
#54TREATMENT OF INFECTIONS AND IMMUNE DYSREGULATION IN PATIENTS WITH PRIMARY IMMUNE DEFICIENCIES USING MRNA-CORRECTED AUTOLOGOUS GRANULOCYTES, LYMPHOCYTES AND/OR NATURAL KILLER CELLS
#55METHODS FOR ISOLATING DIFFERENT TYPES OF SINGLE CELLS FROM OVARY
#56Multilayered blood product
#57Indirect ultrasonic cavitation-derived perivascular cells and methods of use thereof
#58EXPANSION OF HPSC-DERIVED GRANULOCYTIC AND LYMPHOID PROGENITORS WITH UM171
#59Exosome preparation for treating disease and application thereof
#60Cellular Targeted Label Delivery System
#61Cellular targeted active ingredient delivery system
#62Polypeptides, cells, and methods involving engineered CD16
#63Method of generating multi-lineage potential cells and multi-lineage potential cells produced therefrom
#64Granulocytic myeloid-derived suppressor cells (GR-MDSC) accumulate in human breastmilk
#65CELLULAR TARGETED PHARMACEUTICALLY ACTIVE SUBSTANCE OR LABEL DELIVERY SYSTEM
#66Cancer-killing cells
#67Methods to enhance microvascular engraftment of bioengineered and primary tissues
#68Methods for generating universal and custom MHC/HLA-compatible hematopoietic progenitor cells
#69METHOD AND DEVICE FOR CONSERVING VIABLE AND FUNCTIONAL HUMAN POLYMORPHONUCLEAR NEUTROPHILS
#70Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells
#71Artificial immune cell emulating selected properties of granulocytes utilizing Fenton-type reactions
#72Methods for monitoring polymorphonuclear myeloid derived suppressor cells
#73Methods of reducing extravasation of inflammatory cells
#74Pure platelet-rich plasma (P-PRP) composition for treatment of subclinical mastitis and methods of producing and using the same
#75Inflammation-targeted neutrophil granulocyte drug delivery system and use thereof
#76Polypeptides, cells, and methods involving engineered CD16
#77Culture medium for cellular immunotherapy
#78METHOD AND DEVICE FOR CONSERVING VIABLE AND FUNCTIONAL HUMAN POLYMORPHONUCLEAR NEUTROPHILS
#79Compositions and methods for treating neutropenia
#80BLOOD DERIVED IMMUNE STIMULATORY COMPOSITIONS
#81Biosensor system for the rapid detection of analytes
#82High efficiency microfluidic purification of stem cells to improve transplants
#83METHOD FOR SCREENING DRUGS FOR TREATING/PREVENTING MYELODYSPLASTIC SYNDROME, ETC.
#84Method for inducing hemoblast differentiation
#85Methods and systems for the reduction of leukocytes in a biological fluid
#86ACTIVATED LEUKOCYTE COMPOSITION AND USES FOR WOUND HEALING
#87MULTILAYERED BLOOD PRODUCT
#88Method for production of eosinophil from pluripotent stem cell
#89METHOD FOR GENERATION OF CONDITIONALLY IMMORTALIZED HEMATOPOIETIC PROGENITOR CELL LINES WITH MULTIPLE LINEAGE POTENTIAL
#90HIGH EFFICIENCY MICROFLUIDIC PURIFICATION OF STEM CELLS TO IMPROVE TRANSPLANTS
#91Nucleated-cell capturing filter and nucleated-cell preparation method using same
#92Human mast cell lines, preparation and uses
#93Methods to produce mast cell culture
#94Activated leukocyte composition and uses for wound healing
#95Derivation of hematopoietic cells from adult mesenchymal stem cells
#96Use of entrained neutrophils to treat metastatic and micrometastatic disease in at risk patients
#97Small molecule inhibitors of protein kinases
#98Composition and Method for Assessing Regulation of Mast Cells
#99Method for producing mast cells from pluripotent stem cells
#100Methods for treating refractory infections in neutropenic individuals
#101Human mast cell line and uses thereof
#102Activated leukocyte composition and uses for wound healing
#103Methods of reducing extravasation of inflammatory cells
#104Compositions, methods and animal models for screening therapeutics for TH2-type disease
#105METHODS AND COMPOSITIONS
#106Multilayered blood product
#107PROCESS FOR ENRICHING BASOPHILS IN A BLOOD SAMPLE
#108Method of producing a population of post-mitotic cells of the neutrophil lineage
#109Generation of mature myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived linCD34CD43CD45progenitors
#110METHOD OF USING STROMA CELLS FROM CORD BLOOD TO EXPAND AND ENGRAFT NUCLEATED CELLS FROM CORD BLOOD
#111Method for production of mast cells from stem cells
#112Modulation of stem and progenitor cell differentiation, assays, and uses thereof
#113Methods for Culturing Human Lung Mast Cells and Uses Thereof
#114Derivation of unlimited quantities of neutrophils or monocyte/dendritic cells
#115METHOD FOR OBTAINING MASTOCYTE LINES FROM PIG TISSUES AND FOR PRODUCING HEPARIN-TYPE MODULES
#116METHOD FOR PRODUCTION OF NEUTROPHILS AND USES THEREFOR
#117Leukocyte stimulation matrix
#118Production of cultured human mast cells and basophils for high throughput small molecule drug discovery
#119Methods for treating refractory infections in neutropenic individuals
#120Method for obtaining mastocyte lines from pig tissues and for producing heparin-type molecules
#121Use of discoidin domain receptor 1 (DDR1) and agents that affect the DDR1/collagen pathway
#122Neutrophil activation by immune response modifier compounds
#123Pig mast cell cultures and uses thereof